Applying NCCN Guidelines for the Treatment of CLL/SLL in Clinical Practice: The Right Agent for the Right Patient at the Right Time

Gain knowledge on how to apply the current NCCN guidelines for the treatment of CLL/SLL to optimize clinical outcomes. After the live webinar, listen to the podcast, and download the associated slideset for use in your clinic.

Share

Program Content

Activities

CLL SLL Therapy
The Importance of Individualizing CLL/SLL Therapy
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 30, 2024

Expires: May 29, 2025

NCCN CLL SLL Guidelines
Aligning Current Clinical Practice With NCCN CLL/SLL Guidelines
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 30, 2024

Expires: May 29, 2025

Emerging treatments in CLL SLL
New and Evolving Treatments in the Management of CLL/SLL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 30, 2024

Expires: May 29, 2025

Activities

Podcast: CLL/SLL Guidelines
Current Clinical Practice and NCCN Guidelines for CLL/SLL
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: July 22, 2024

Expires: July 21, 2025

Faculty

cover img faculity

Jeremy S. Abramson, MD, MMSc

Director, Center for Lymphoma
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Farrukh T. Awan, MD, MS, MBA

Associate Director, Section of Hematologic Malignancies/Transplantation and Cellular Therapy
Director of Lymphoid Malignancies Program
Harold C. Simmons Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Dallas, Texas

cover img faculity

Shuo Ma, MD, PhD

Professor of Medicine
Division of Hematology/Oncology
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC

Supporters

Supported by educational grants from BeiGene; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Lilly. Supported by an independent medical education grant from AbbVie.

AbbVie

BeiGene

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Lilly

Partners

Clinical Care Options, LLC

ProCE Banner